Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxoprexin in advanced liver cancer
NCT00422877Phase 2Terminated
- Sponsor
- American Regent, Inc.
- Start
- Jan 2007
- Primary completion
- Mar 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel docosahexaenoic acid in hepatocellular carcinoma (HCC), gallbladder cancer, biliary tract cancer (BTC), sponsored by American Regent, Inc.. Started Jan 2007; status: terminated.
02
Drugs
paclitaxel docosahexaenoic acid
03
Conditions
hepatocellular carcinoma (HCC)gallbladder cancerbiliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00422877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422877.